BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Authors
» Nuala Moran
Nuala Moran
Articles
ARTICLES
UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests
April 11, 2001
By
Nuala Moran
Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial
April 11, 2001
By
Nuala Moran
Diversys Enters $10M Alliance, Secures $10M In Private Funding
April 11, 2001
By
Nuala Moran
Diversys Enters $10M Alliance, Secures $10M In Private Funding
April 11, 2001
By
Nuala Moran
Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial
April 11, 2001
By
Nuala Moran
UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests
April 11, 2001
By
Nuala Moran
Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms
April 4, 2001
By
Nuala Moran
Oxford Gene, Affymetrix Settle Microarray Patent Litigation
April 4, 2001
By
Nuala Moran
Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms
April 4, 2001
By
Nuala Moran
Oxford Gene, Affymetrix Settle Microarray Patent Litigation
April 4, 2001
By
Nuala Moran
View All Articles by Nuala Moran
